HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

12/04

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures,…

STEP-UP 2013-2017 impact assessment report is out

08/04

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research

05/04

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and…

Corporate reputation of pharma in 2018 – the global patient perspective

18/04

Corporate reputation of pharma in 2018: What 1, 500 patient groups from around the world think of 46 pharma companies…

Novel antibody may suppress HIV for up to four months

18/04

NIAID researchers, international collaborators report results of small, open-label study Regular infusions of an antibody that blocks the HIV binding…

In rare cases, immune system fails despite HIV suppression

18/04

NIAID scientists identify paradoxical response to HIV medication in five individuals Antiretroviral therapy (ART) is usually very effective at suppressing…

HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

12/04

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures,…

STEP-UP 2013-2017 impact assessment report is out

08/04

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research

05/04

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and…

Corporate reputation of pharma in 2018 – the global patient perspective

18/04

Corporate reputation of pharma in 2018: What 1, 500 patient groups from around the world think of 46 pharma companies…

Novel antibody may suppress HIV for up to four months

18/04

NIAID researchers, international collaborators report results of small, open-label study Regular infusions of an antibody that blocks the HIV binding…

In rare cases, immune system fails despite HIV suppression

18/04

NIAID scientists identify paradoxical response to HIV medication in five individuals Antiretroviral therapy (ART) is usually very effective at suppressing…